Discover more from NewLimit Blog
We've added two members to our Scientific Advisory Board: Alex Marson and Mark M. Davis
We’re excited to announce the initial two members of our Scientific Advisory Board. Both Alex and Mark bring a wealth of experience that will help guide our scientific exploration of radically extending human healthspan through epigenetic reprogramming.
Alex Marson is a Professor at UCSF, scientific director of human health at the Innovative Genomics Institute (IGI) and head of the Gladstone-UCSF Institute of Genomic Immunology. Dr. Marson’s research goal is to understand the genetic circuits that control human immune cell function. Dr. Marson’s team has pioneered new CRISPR gene editing technologies that offer more precise ways to rewrite DNA programs in human immune cells.
Dr. Marson received an AB from Harvard, an MD from Harvard and a PhD from MIT. Alex completed internal Medicine residency at Brigham and Women’s and an Infectious Diseases fellowship at UCSF.
Mark M Davis
Mark M. Davis is the Director of the Stanford Institute for Immunology, Transplantation and Infection, a Professor of Microbiology and Immunology, and a Howard Hughes Medical Institute Investigator.
Dr. Davis is well known for identifying many of the T-cell receptor genes, which are responsible for the ability of these cells to recognize a diverse repertoire of antigens. His current research focuses on obtaining a “systems level” understanding of the human immune system, including the steady state and vaccine responses of old and young subjects.
Dr. Davis received a BA from Johns Hopkins University and a Ph.D. from the California Institute of Technology.